Literature DB >> 18392399

Clinical, electrocardiographic and echocardiographic findings in significant cardiac amyloidosis detected only at necropsy: comparison with cases diagnosed in life.

Paulo Sampaio Gutierrez1, Fábio Fernandes, Charles Mady, Maria de Lourdes Higuchi.   

Abstract

BACKGROUND: Currently, many cases of heart amyloidosis still fail to be diagnosed.
OBJECTIVE: To disclose factors related to the difficulty in attaining the diagnosis of cardiac amyloidosis.
METHODS: We compared the clinical, electrocardiographic and echocardiographic data of 17 patients in whom amyloidosis was diagnosed only at the necropsy (group I) with data from 9 patients in whom the disease was diagnosed in life (group II). The quantitative variables were compared by t-test and qualitative ones by Fisher's exact test. Significance was set at p< or = 0.05.
RESULTS: The two groups showed differences regarding age (group I: 75.29 +/- 11.61, group II: 58.67 +/- 11.07 years), association with other cardiac disease (group I: 52.94%, group II: 0%), low voltage at the ECG (group I: 17.65%, group II: 66.67%), and diastolic dysfunction at the echocardiogram (group I: 7.69%, group II: 62.50%). Some degree of left ventricular thickening was found in 75% of necropsy cases and 100% of controls (p=0.23), but wall thickness was lower in group I (free left ventricular wall: 1.20 +/- 0.28 cm versus 1.53 +/- 0.18 cm in group II, p=0.01). Systolic dysfunction was present in 57.89% of the cases, without significant difference between the groups.
CONCLUSION: Amyloidosis is diagnosed when the clinical, ECG, and echocardiogram patterns are "typical", but most of the cases fail to be diagnosed, especially in elderly people, due to the association with other cardiac diseases, lack of diastolic dysfunction at the echocardiogram and only a slightly thickened ventricular wall.

Entities:  

Mesh:

Year:  2008        PMID: 18392399     DOI: 10.1590/s0066-782x2008000300009

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  6 in total

1.  Case 3/2014--81-year-old patient hospitalized for decompensated heart failure.

Authors:  Bruna Affonso Madaloso; Paulo Sampaio Gutierrez
Journal:  Arq Bras Cardiol       Date:  2014-07       Impact factor: 2.000

2.  Speckle Tracking and Transthyretin Amyloid Cardiomyopathy.

Authors:  Alexandre Marins Rocha; Suzane Garcia Ferreira; Marcelo Souto Nacif; Mario Luiz Ribeiro; Marcos Raimundo Gomes de Freitas; Cláudio Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2016-12-19       Impact factor: 2.000

3.  Right Atrial Deformation Analysis in Cardiac Amyloidosis - Results from the Three-Dimensional Speckle-Tracking Echocardiographic MAGYAR-Path Study.

Authors:  Attila Nemes; Dóra Földeák; Péter Domsik; Anita Kalapos; Árpád Kormányos; Zita Borbényi; Tamás Forster
Journal:  Arq Bras Cardiol       Date:  2018-08-20       Impact factor: 2.000

Review 4.  Deposit Diseases as Differential Diagnosis of Left Ventricular Hypertrophy in Patients with Heart Failure and Preserved Systolic Function.

Authors:  Fábio Fernandes; Murillo Oliveira Antunes; Viviane Tiemi Hotta; Carlos Eduardo Rochitte; Charles Mady
Journal:  Arq Bras Cardiol       Date:  2019-11       Impact factor: 2.000

5.  Updates in cardiac amyloidosis: a review.

Authors:  Sanjay M Banypersad; James C Moon; Carol Whelan; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

6.  The value of necropsy in quality control of medical diagnosis: the gold standard for years to come.

Authors:  Paulo Sampaio Gutierrez; Thales de Brito; Maria Beatriz Sampaio Lopes; Venancio Avancini Ferreira Alves
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.